SCHEMBL6964052

SCHEMBL6964052

NC(=O)C1c2cc[c]cc2CCN1C(=O)CC1=CCCC1

nearest known ligand 0.33

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ACE P12821 1/20 0.33
KDM4E B2RXH2 1/20 0.31
F2RL1 P55085 1/20 0.30
DRD1 P21728 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6965563 0.80 PARP1 (0.42) KDM4EDRD1
SCHEMBL6970725 0.80 SMN1; SMN2 (0.42) KDM4E
SCHEMBL6973366 0.79 ACE (0.41) ACEKDM4E
SCHEMBL6964658 0.78 HTT (0.38) ACEKDM4E
SCHEMBL6974644 0.78 CYP1A2 (0.40) ACEKDM4E
SCHEMBL6974704 0.78 MAPT (0.40) ACEKDM4E
SCHEMBL6972676 0.78 ACE (0.36) ACEF2RL1
SCHEMBL6957854 0.78 GHSR (0.38) ACEKDM4EF2RL1DRD1
SCHEMBL6960911 0.78 ACE (0.36) ACEF2RL1
SCHEMBL6969731 0.77 KCNH2 (0.39) ACEKDM4EF2RL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996040640-A1 BIPHENYL-2-CARBOXYLIC ACID-TETRAHYDRO-ISOQUINOLIN-6-YL AMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND/OR APOLIPOPROTEIN B (Apo B) SECRETION PFIZER INC. (US) 1996-12-19 WO claimed
EP-0832069-B1 BIPHENYL-2-CARBOXYLIC ACID-TETRAHYDRO-ISOQUINOLIN-6-YL AMIDE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS INHIBITORS OF MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN AND/OR APOLIPOPROTEIN B (Apo B) SECRETION PFIZER (US) 2003-03-05 EP disclosed
EP-1181954-A2 Biphenyl-2-carboxylic acid-tetrahydro-isoquinolin-6-yl amide derivatives, their preparation and use as inhibitors of microsomal triglyceride transfer protein and/or apolipoprotein B (ApoB) secretion PFIZER INC. (US) 2002-02-27 EP disclosed